. 2018 Jun 19;81(4):319–329. doi: 10.4046/trd.2017.0122

Table 2. Clinical status in 33 cases of acute respiratory failures received bronchoalveolar lavage (BAL) using high-flow nasal cannula oxygen delivery.

No	Age (yr)/ Sex	PF ratio	Before BAL			After BAL			During BAL			Procedure time (min)	Intubation^* (time to intubation, hr)	Immune Suppression	6-Month survival	Complications	Pre-BAL diagnosis	Infectious agent	Post-BAL diagnosis	Treatment change
No	Age (yr)/ Sex	PF ratio	FiO₂	Flow (L/min)	SpO₂ (%)	FiO₂	Flow (L/min)	SpO₂ (%)	FiO₂	Flow (L/min)	SpO₂ (%)	Procedure time (min)	Intubation^* (time to intubation, hr)	Immune Suppression	6-Month survival	Complications	Pre-BAL diagnosis	Infectious agent	Post-BAL diagnosis	Treatment change
1	80/F	109.6	0.7	40	93	0.9	40	98	0.8	40	90	20	+ (26)	-	Expired	THX, fever	PN	Acinetobacter baumanii	PN	-
2	56/M	165.6	0.6	50	90	0.9	50	96	0.6	50	90	5	+ (76)	-	Expired	THX, fever	ILD	-	ILD	-
3	43/F	133.3	0.4	5	96	0.7	60	98	0.7	60	98	20	-	-	Expired	Fever	PN	-	AH	+
4^†	42/F	165.3	0.4	5	97	0.9	50	96	0.4	5	95	30	-	-	Expired	Fever	PN	PCP	APN	+
5^†	42/F	173.8	0.4	5	93	0.94	50	94	0.65	50	98	30	-	-	Expired	THX, fever	APN	PCP	APN	-
6	71/M	159.3	0.4	5	98	0.5	50	98	0.5	50	96	20	-	-	Survived	Fever	PN	-	PN	-
7	83/M	138.9	0.45	47	98	0.7	47	96	0.5	47	97	20	-	-	Survived	-	PN	-	OP	+
8	73/F	115.8	0.5	50	90	0.9	50	95	0.6	50	98	15	-	-	Survived	-	PN	-	OP	+
9	56/M	200.0	0.4	30	98	0.56	50	91	0.5	40	99	15	-	-	Expired	THX	PN	Staphylococcusaureus	PN	+
10	68/F	212.3	0.4	5	96	0.6	50	97	0.4	5	96	15	-	-	Survived	Hypotension	PN	A. baumanii,S. aureus	PN	+
11	82/F	213.9	0.4	5	99	0.6	45	99	0.4	5	96	9	-	+	Survived	-	APN	-	APN	-
12	53/M	269.5	0.4	40	97	0.4	40	90	0.4	40	99	25	+ (32)	-	Expired	THX	APN	RSV	APN	+
13	23/M	203.8	0.3	3	96	1.0	55	86	0.6	40	94	7	-	-	Survived	THX	APN	-	AEP	+
14	70/M	149.5	0.4	30	96	0.6	50	90	0.4	30	95	9	-	-	Survived	-	PN	CMV	APN	+
15	73/F	106.3	0.6	50	94	0.8	55	92	0.7	50	93	10	+ (70)	-	Expired	THX, fever	APN	-	APN	-
16	58/M	178.2	0.6	50	91	1.0	50	88	0.8	50	91	21	-	-	Survived	THX	PN	RSV	OP	+
17	64/M	120.8	0.4	40	96	0.8	50	90	0.4	40	96	7	-	-	Survived	-	PN	-	PN	-
18	69/M	128.0	0.4	35	98	0.4	35	97	0.4	35	97	9	-	-	Expired	-	PN	-	PN	-
19	64/F	248.0	0.4	40	100	0.8	40	97	0.4	40	98	7	-	-	Survived	-	APN	-	APN	-
20	76/F	123.1	0.65	45	98	1.0	60	94	0.65	45	95	20	+ (78)	+	Expired	THX	APN	-	APN	-
21	70/M	244.6	0.28	2	92	0.6	40	95	0.8	15	96	8	+ (144)	-	Expired	THX, fever	ILD	Candida albicans	APN	+
22	56/F	189.4	0.32	3	91	0.6	40	96	0.6	40	98	25	-	+	Expired	THX	APN	CMV	APN	+
23	72/M	159.4	0.4	5	92	0.7	40	95	0.6	50	98	17	-	+	Expired	THX	APN	CMV	APN	+
24	64/M	184.7	0.32	3	90	0.7	50	96	0.4	40	92	17	+ (120)	-	Expired	THX, fever	APN	-	APN	-
25	36/F	136.8	0.7	50	95	1.0	50	88	0.8	50	90	5	-	-	Survived	THX	PN	-	OP	+
26	81/M	128.8	0.5	40	94	0.9	60	94	0.5	40	93	5	-	-	Survived	THX	PN	C. albicans	PN	-
27	68/F	156.0	0.5	40	96	0.7	50	94	0.6	50	93	10	+ (72)	+	Expired	THX	AH	-	AH	-
28	43/M	89.1	0.7	60	91	0.8	60	93	0.8	60	95	7	+ (274)	+	Expired	THX	APN	PCP, CMV, Rhinovirus	APN	+
29	71/M	208.9	0.28	2	91	0.5	40	98	0.5	40	97	15	-	-	Expired	-	PN	-	PN	+
30	81/F	245.8	0.4	40	95	0.8	50	97	0.6	50	100	12	-	+	Expired	-	PN	C. albicans	ILD	+
31	80/F	141.0	0.4	5	98	1.0	60	100	0.6	50	93	14	-	+	Expired	-	APN	-	APN	-
32	64/M	102.6	0.5	40	95	0.8	60	95	0.7	50	92	8	-	-	Survived	-	PN	S. aureus	PN	+
33	75/M	179.2	0.4	5	95	0.4	40	99	0.4	40	95	18	-	-	Survived	-	PN	Pseudomonas aeruginosa	PN	+

^*Cases for endotracheal intubation were followed until 2 weeks after the BAL procedure. ^†One patient received bronchoscopy twice for BAL.

PF ratio: baseline PaO₂/FiO₂; FiO₂: fraction of inspired oxygen; Flow: gas flow rate; SpO₂: oxygen saturation recorded by pulse oximetry; F: female; THX: transient hypoxemia; PN: bacterial pneumonia; M: male; ILD: interstitial lung disease; AH: alveolar hemorrhage; PCP: Pneumocystis jiroveci pneumonia; APN: atypical pneumonia; OP: organizing pneumonia; RSV: respiratory syncytial virus; AEP: acute eosinophilic pneumonia; CMV: cytomegalovirus.